FMR CORP 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:28 am Sale |
2024-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
FMR CORP | 4,740 0.200% |
-158,109 (-97.09%) |
Filing |
| 2024-02-09 08:50 am Purchase |
2024-02-08 | 13G | Cyclerion Therapeutics, Inc. CYCN |
FMR CORP | 162,849 6.660% |
162,849 (New Position) |
Filing |